Zydus Wellness Ltd

Zydus Wellness Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Zydus Wellness Ltd

₹ 1,632 0.20%
19 Apr - close price
zyduswellness.in BSE: 531335 NSE : ZYDUSWELL
About

Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)

Key Points

Product Portfolio
The Company’s product portfolio includes brands like Glucon-D, Complan, Sugar-Free, Nycil, Everyuth, and Nutralite offering products such as Glucose Powder, Face wash, Scrub, Peel-Off, Face masks, Sugar Substitute, Blended Sugar, etc [1]

Website BSE NSE
  • Market Cap ₹ 10,383 Cr.
  • Current Price ₹ 1,632
  • High / Low ₹ 1,721 / 1,425
  • Stock P/E 189
  • Book Value ₹ 631
  • Dividend Yield 0.31 %
  • ROCE 1.19 %
  • ROE 1.65 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 93.6%

Cons

  • Stock is trading at 2.58 times its book value
  • Tax rate seems low
  • Company has a low return on equity of 0.20% over last 3 years.
  • Earnings include an other income of Rs.16.9 Cr.
  • Working capital days have increased from 59.3 days to 144 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Food - Processing - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
38 42 33 52 71 60 62 67 64 59 60 58 64
45 57 47 57 61 57 56 55 51 51 53 50 53
Operating Profit -8 -14 -14 -5 10 4 5 12 12 8 7 8 11
OPM % -20% -34% -44% -9% 14% 6% 9% 19% 20% 14% 12% 13% 17%
-119 6 4 4 4 4 4 3 3 4 4 5 5
Interest 5 0 0 0 1 0 0 -0 1 0 -0 1 1
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax -133 -10 -11 -2 13 6 8 14 14 10 10 10 14
Tax % -0% -0% -0% -0% -0% -126% -0% -4% -4% -173% 21% 25% 24%
-133 -10 -11 -2 13 13 8 15 15 29 8 8 10
EPS in Rs -20.89 -1.57 -1.77 -0.32 1.97 2.11 1.26 2.33 2.36 4.51 1.29 1.23 1.62
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
254 213 203 219 200 225 264 255 153 114 216 251 240
181 125 122 126 122 137 152 182 174 164 222 213 207
Operating Profit 72 88 81 93 78 88 112 72 -21 -50 -5 38 34
OPM % 28% 41% 40% 42% 39% 39% 42% 28% -14% -44% -2% 15% 14%
9 14 12 20 30 25 28 57 109 -60 15 13 17
Interest 0 0 0 0 0 0 2 30 140 75 2 1 2
Depreciation 2 2 2 5 4 4 4 3 3 3 3 4 4
Profit before tax 79 99 91 109 104 109 134 97 -55 -188 5 47 45
Tax % 14% 2% -6% -0% 1% -1% 0% 1% 26% 3% -143% -41%
68 97 96 109 103 109 134 96 -41 -182 13 66 55
EPS in Rs 17.32 24.85 24.69 27.88 26.43 27.98 34.24 16.70 -7.06 -28.62 2.00 10.44 8.65
Dividend Payout % 29% 24% 24% 22% 25% 23% 23% 30% -71% -17% 251% 48%
Compounded Sales Growth
10 Years: 2%
5 Years: -1%
3 Years: 18%
TTM: -5%
Compounded Profit Growth
10 Years: -4%
5 Years: -13%
3 Years: 54%
TTM: 7%
Stock Price CAGR
10 Years: 12%
5 Years: 5%
3 Years: -8%
1 Year: 7%
Return on Equity
10 Years: 3%
5 Years: 0%
3 Years: 0%
Last Year: 2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 39 39 39 39 39 39 39 58 58 64 64 64 64
Reserves 148 217 286 367 440 518 652 3,268 3,157 3,956 3,937 3,971 3,955
-0 -0 -0 -0 -0 25 25 1,566 1,516 50 46 0 50
54 49 48 45 19 23 23 62 72 47 44 32 28
Total Liabilities 241 306 373 451 498 605 739 4,954 4,803 4,116 4,090 4,067 4,096
53 51 53 44 43 40 38 37 43 44 45 55 54
CWIP -0 -0 -0 -0 0 0 0 1 1 1 2 0 3
Investments 48 96 146 100 209 254 294 3,690 3,528 3,671 3,683 3,698 3,691
140 158 175 306 245 310 407 1,226 1,231 400 360 314 349
Total Assets 241 306 373 451 498 605 739 4,954 4,803 4,116 4,090 4,067 4,096

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
59 77 88 89 79 88 113 86 -20 -52 -16 37
-1 -35 -42 70 -19 -78 -109 -4,131 267 816 39 1
-18 -23 -27 -27 -58 -6 -2 4,049 -260 -710 -38 -79
Net Cash Flow 39 19 18 131 1 4 2 4 -13 54 -15 -42

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 1 1 0 1 0 1 1 9 1 5 19 4
Inventory Days 26 44 34 25 23 38 32 24 57 67 22 20
Days Payable 105 99 94 58 71 93 84 106 151 158 75 44
Cash Conversion Cycle -79 -55 -60 -32 -48 -55 -50 -73 -93 -85 -34 -20
Working Capital Days -60 -64 -71 -63 -23 -20 -16 -8 -26 15 19 144
ROCE % 48% 45% 31% 30% 23% 21% 21% 4% 2% 0% 0% 1%

Shareholding Pattern

Numbers in percentages

3 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
64.82% 64.82% 64.82% 64.82% 65.14% 65.36% 65.36% 66.45% 67.11% 68.54% 69.15% 69.62%
2.96% 2.94% 3.39% 2.56% 2.38% 3.24% 3.83% 3.87% 3.23% 3.42% 3.25% 3.26%
24.76% 25.49% 24.80% 25.11% 25.11% 23.78% 23.35% 22.18% 22.04% 20.22% 19.67% 19.41%
7.46% 6.75% 6.99% 7.51% 7.37% 7.62% 7.46% 7.51% 7.62% 7.81% 7.91% 7.71%
No. of Shareholders 58,03555,51359,82367,20866,84570,70968,96970,79073,02976,59075,36969,138

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls